Nuvation Bio (NUVB) Change in Acquisitions & Divestments (2020 - 2026)

Nuvation Bio (NUVB) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $38.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 66.46% year-over-year to $38.6 million; the TTM figure through Mar 2026 stood at $385.9 million (down 10.06% YoY), while the FY2025 annual figure was $462.3 million, up 2.71% from the prior year.
• Change in Acquisitions & Divestments declined to $38.6 million in Q1 2026 per NUVB's latest filing, from $132.1 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $244.2 million in Q2 2023 and bottomed at $38.6 million in Q1 2026.
• Historically, Change in Acquisitions & Divestments has averaged $132.2 million across 5 years, with a median of $126.1 million in 2022.
• Annual changes were most pronounced in 2022 — Change in Acquisitions & Divestments soared 485.18% — and 2026, when it sank 66.46%.
• Nuvation Bio's Change in Acquisitions & Divestments stood at $115.9 million in 2022, then soared by 56.89% to $181.9 million in 2023, then sank by 53.88% to $83.9 million in 2024, then soared by 57.43% to $132.1 million in 2025, then plunged by 70.81% to $38.6 million in 2026.
• Business Quant data shows NUVB's Change in Acquisitions & Divestments at $38.6 million in Q1 2026, $132.1 million in Q4 2025, and $78.5 million in Q3 2025.